首页 > 最新文献

Gastrointestinal Tumors最新文献

英文 中文
Huge Gastrointestinal Stromal Tumor of the Jejunum Presenting as Bowel Obstruction: A Rare Presentation 空肠巨大胃肠道间质瘤表现为肠梗阻:罕见的表现
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-08-20 DOI: 10.1159/000501744
Tanweerul Huda, M. Singh
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract arising from interstitial Cajal cells. A 54-year-old male patient without any comorbidities presented to the emergency department with complaints of abdominal distension, inability to pass flatus, and no motion for the past 2 days. Abdominal X-ray showed multiple air-fluid levels suggesting bowel obstruction. The patient was managed conservatively at first. Later, ultrasonography and contrast-enhanced computed tomography (CECT) of the abdomen were done, which revealed a mass lesion arising from the jejunum suggestive of GIST. The patient was taken up for exploratory laparotomy, and a tumor was found in the proximal jejunum around 10 cm from the duodenojejunal junction and encompassing the hepatic flexure of the transverse colon, with the omentum found adhered to the anterior surface of the lesion and distended proximal bowel loops. There was no evidence of mesenteric lymphadenopathy. The mass was resected along with the jejunal loop and the hepatic flexure of the colon, followed by end-to-end jejunojejunal anastomosis and end-to-end colocolic anastomosis. The patient’s postoperative stay was uneventful. Imatinib therapy was started following histopathological confirmation and continued. The patient was followed up for 1 year postoperatively with CECT of the abdomen every 6 months, with no evidence of recurrence or any gastrointestinal symptoms.
胃肠道间质肿瘤(gist)是由间质Cajal细胞引起的胃肠道间质肿瘤。54岁男性患者,无任何合并症,以腹胀、不能排气、过去2天无运动等主诉就诊于急诊科。腹部x光片显示多个气液水平表明肠梗阻。病人最初接受保守治疗。随后,腹部超声和增强ct (CECT)显示空肠出现肿块,提示GIST。患者行剖腹探查术,发现空肠近端肿瘤,距十二指肠空肠交界处约10cm,环绕横结肠肝曲,发现大网膜粘附病变前表面,近端肠袢扩张。没有肠系膜淋巴结病的证据。切除肿物,同时切除空肠袢和结肠肝曲,行空肠-空肠端到端吻合和结肠端到端吻合。病人术后的住院很顺利。组织病理学证实后开始伊马替尼治疗并继续治疗。术后随访1年,每6个月进行一次腹部ct检查,未见复发或任何胃肠道症状。
{"title":"Huge Gastrointestinal Stromal Tumor of the Jejunum Presenting as Bowel Obstruction: A Rare Presentation","authors":"Tanweerul Huda, M. Singh","doi":"10.1159/000501744","DOIUrl":"https://doi.org/10.1159/000501744","url":null,"abstract":"Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract arising from interstitial Cajal cells. A 54-year-old male patient without any comorbidities presented to the emergency department with complaints of abdominal distension, inability to pass flatus, and no motion for the past 2 days. Abdominal X-ray showed multiple air-fluid levels suggesting bowel obstruction. The patient was managed conservatively at first. Later, ultrasonography and contrast-enhanced computed tomography (CECT) of the abdomen were done, which revealed a mass lesion arising from the jejunum suggestive of GIST. The patient was taken up for exploratory laparotomy, and a tumor was found in the proximal jejunum around 10 cm from the duodenojejunal junction and encompassing the hepatic flexure of the transverse colon, with the omentum found adhered to the anterior surface of the lesion and distended proximal bowel loops. There was no evidence of mesenteric lymphadenopathy. The mass was resected along with the jejunal loop and the hepatic flexure of the colon, followed by end-to-end jejunojejunal anastomosis and end-to-end colocolic anastomosis. The patient’s postoperative stay was uneventful. Imatinib therapy was started following histopathological confirmation and continued. The patient was followed up for 1 year postoperatively with CECT of the abdomen every 6 months, with no evidence of recurrence or any gastrointestinal symptoms.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"116 - 121"},"PeriodicalIF":1.6,"publicationDate":"2019-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000501744","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45670576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience 胰腺分泌胰岛素原神经内分泌肿瘤:单中心经验
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-08-13 DOI: 10.1159/000501455
A. Kriger, S. Berelavichus, A. Kaldarov, V. Panteleev, D. Gorin, R. S. Dugarova, M. Yukina
Background: Proinsulinoma is a neuroendocrine tumor (NET) of the pancreas that produces prohormone proinsulin. These tumors are very rare. In the literature, they are most often presented in the form of case reports. Materials and Methods: We studied 177 patients with NET of the pancreas who underwent surgical treatment in the A.V. Vishnevsky National Medical Research Centre of Surgery from January 2007 to December 2018. Results: Of 81 patients with organic hyperinsulinism caused by functioning NETs of the pancreas during the study period, 3 (3.7%) had a proinsulinoma; 2 were female; and 1 was male. None of them admitted to weight gain during this period, and their BMI was normal. All patients presented with Whipple’s triad during the 72-h fast. Tumor-enucleating surgery was performed: one robot assisted, two laparotomies. A normal glucose level after treatment was achieved in all cases. Conclusion: In cases where clinical hypoglycemia is present, but the serum insulin level is within the normal range or even decreased, proinsulinoma should be suspected. For now, surgical resection remains the only effective method of treatment. Further investigation of proinsulinomas is needed.
背景:胰岛素原瘤是胰腺的一种神经内分泌肿瘤(NET),产生激素原胰岛素。这些肿瘤非常罕见。在文献中,它们通常以病例报告的形式呈现。材料与方法:我们研究了2007年1月至2018年12月在A.V. Vishnevsky国家外科医学研究中心接受手术治疗的177例胰腺NET患者。结果:研究期间81例由胰腺功能net引起的器质性高胰岛素血症患者中,3例(3.7%)发生胰岛素原瘤;2名女性;我是男性。他们中没有人承认在此期间体重增加,他们的体重指数是正常的。所有患者在72小时禁食期间均出现惠普尔三联征。进行肿瘤去核手术:一个机器人辅助,两个剖腹手术。所有病例治疗后血糖均达到正常水平。结论:临床出现低血糖,但血清胰岛素水平在正常范围内甚至下降时,应怀疑为胰岛素原瘤。目前,手术切除仍是唯一有效的治疗方法。需要进一步研究胰岛素原瘤。
{"title":"Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience","authors":"A. Kriger, S. Berelavichus, A. Kaldarov, V. Panteleev, D. Gorin, R. S. Dugarova, M. Yukina","doi":"10.1159/000501455","DOIUrl":"https://doi.org/10.1159/000501455","url":null,"abstract":"Background: Proinsulinoma is a neuroendocrine tumor (NET) of the pancreas that produces prohormone proinsulin. These tumors are very rare. In the literature, they are most often presented in the form of case reports. Materials and Methods: We studied 177 patients with NET of the pancreas who underwent surgical treatment in the A.V. Vishnevsky National Medical Research Centre of Surgery from January 2007 to December 2018. Results: Of 81 patients with organic hyperinsulinism caused by functioning NETs of the pancreas during the study period, 3 (3.7%) had a proinsulinoma; 2 were female; and 1 was male. None of them admitted to weight gain during this period, and their BMI was normal. All patients presented with Whipple’s triad during the 72-h fast. Tumor-enucleating surgery was performed: one robot assisted, two laparotomies. A normal glucose level after treatment was achieved in all cases. Conclusion: In cases where clinical hypoglycemia is present, but the serum insulin level is within the normal range or even decreased, proinsulinoma should be suspected. For now, surgical resection remains the only effective method of treatment. Further investigation of proinsulinomas is needed.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"64 - 70"},"PeriodicalIF":1.6,"publicationDate":"2019-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000501455","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48723331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review. 青少年纤维板层型肝细胞癌一例报告及文献复习。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-08-01 DOI: 10.1159/000499581
Javier Santiago-Reynoso, Karina Senyase Zamaripa-Martínez, Juan Manuel Dorantes-Loya, Guillermo J Gaytán-Fernández, Evelia Apolinar-Jiménez, Francisco Paz-Gómez, Felipe Farias-Serratos, María Maldonado-Vega

We present a female patient, 13 years old, with diagnosis of hepatocellular carcinoma of fibrolamellar type, which was rapidly evolving. The fibrolamellar hepatocellular carcinoma invaded more than 80% of the hepatic parenchyma without surgical possibility or liver transplantation. Measures applied corresponded to chemotherapy of 1 cycle of cisplatin 40 mg/s/5 days + vincristine 1.5 mg/m2/day, 5-fluorouracil, doxorubicin, and dexrazoxane. The case presented aggressive evolution of hepatocellular carcinoma, which led to acute liver failure, with hyperammonemia, sepsis, pulmonary focus plus septic shock, grade III-IV encephalopathy, portal hypertension, and ascites with intra-abdominal hypertension. Death occurred due to multiple organ failure, which involved respiratory failure type KDIGO 1 and 2, acute liver failure, severe pneumonia, pericardial effusion, AKIN 2 acute kidney injury, carcinoma, and pulmonary metastasis. This type of ailment is infrequent in children and adolescents, and the first symptoms are crucial to achieve treatment possibilities.

我们报告一位13岁的女性患者,诊断为纤维板层型肝细胞癌,其发展迅速。纤维板层型肝细胞癌侵袭80%以上的肝实质,不能进行手术或肝移植。化疗方案为顺铂40mg /s/5天+长春新碱1.5 mg/m2/天、5-氟尿嘧啶、阿霉素、右唑嗪。该病例表现为肝细胞癌的侵袭性发展,导致急性肝功能衰竭,伴高氨血症、败血症、肺灶合并感染性休克、III-IV级脑病、门脉高压、腹水伴腹内高压。多器官衰竭导致死亡,包括呼吸衰竭KDIGO 1型和2型、急性肝衰竭、严重肺炎、心包积液、AKIN 2型急性肾损伤、癌和肺转移。这种类型的疾病在儿童和青少年中并不常见,最初的症状对于实现治疗的可能性至关重要。
{"title":"Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review.","authors":"Javier Santiago-Reynoso,&nbsp;Karina Senyase Zamaripa-Martínez,&nbsp;Juan Manuel Dorantes-Loya,&nbsp;Guillermo J Gaytán-Fernández,&nbsp;Evelia Apolinar-Jiménez,&nbsp;Francisco Paz-Gómez,&nbsp;Felipe Farias-Serratos,&nbsp;María Maldonado-Vega","doi":"10.1159/000499581","DOIUrl":"https://doi.org/10.1159/000499581","url":null,"abstract":"<p><p>We present a female patient, 13 years old, with diagnosis of hepatocellular carcinoma of fibrolamellar type, which was rapidly evolving. The fibrolamellar hepatocellular carcinoma invaded more than 80% of the hepatic parenchyma without surgical possibility or liver transplantation. Measures applied corresponded to chemotherapy of 1 cycle of cisplatin 40 mg/s/5 days + vincristine 1.5 mg/m<sup>2</sup>/day, 5-fluorouracil, doxorubicin, and dexrazoxane. The case presented aggressive evolution of hepatocellular carcinoma, which led to acute liver failure, with hyperammonemia, sepsis, pulmonary focus plus septic shock, grade III-IV encephalopathy, portal hypertension, and ascites with intra-abdominal hypertension. Death occurred due to multiple organ failure, which involved respiratory failure type KDIGO 1 and 2, acute liver failure, severe pneumonia, pericardial effusion, AKIN 2 acute kidney injury, carcinoma, and pulmonary metastasis. This type of ailment is infrequent in children and adolescents, and the first symptoms are crucial to achieve treatment possibilities.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1-2","pages":"43-50"},"PeriodicalIF":1.6,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000499581","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10466637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Front & Back Matter 正面和背面
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-08-01 DOI: 10.1159/000502464
A. Tannapfel, A. Reinacher-Schick, Jing-yuan Fang, P. Malfertheiner
{"title":"Front & Back Matter","authors":"A. Tannapfel, A. Reinacher-Schick, Jing-yuan Fang, P. Malfertheiner","doi":"10.1159/000502464","DOIUrl":"https://doi.org/10.1159/000502464","url":null,"abstract":"","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"1 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49141963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Jejunal Gastrointestinal Stromal Tumor: Diagnosis Delay of 3 Years but Successful Management in Early Stage (II) by Surgery and Adjuvant Therapy. 原发性空肠胃肠道间质瘤:诊断延迟3年但早期成功治疗(II)通过手术和辅助治疗。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-08-01 Epub Date: 2019-04-03 DOI: 10.1159/000496973
Ferdous Ara Begum, Md Arifur Rahman, Hashim Rabbi, Golam Mostofa, Qamruzzaman Chowdhury

In the digestive system, mesenchymal origin of tumors is quite rare; in general, they are recognized as gastrointestinal stromal tumors (GISTs). The incidence of GISTs is very low (2 in 100,000), while jejunal GISTs are extremely rare, accounting for 0.1-3% of all gastrointestinal (GI) tumors. Small intestinal GISTs are the second most common (25%) site in the GI tract, usually occurring in the duodenum. We present the case of a 62-year-old Bangladeshi female with a history of GI bleeding 3 years earlier; the cause of the bleeding had not been found despite extensive investigations. In the meantime, the patient had developed occasional abdominal pain and lumpy feelings in the right side of the abdomen without any GI bleeding. Exploratory laparotomy was carried out in view of a small intestinal mesenteric mass in a computed tomography scan. On midline incision there was a 6 × 6 cm mass in the antimesenteric border of the jejunum approximately 30 cm from the duodenojejunal flexure, which was resected followed by anastomosis. The presentation of GISTs ranges from asymptomatic to mild abdominal pain and mass (5-50%) and mechanical obstruction (5%) as well as hemorrhage - perforation having rarely been reported (0.8%) - making the diagnosis difficult. Exophytic growth of these tumors has been noted in 18-30% of cases. In view of intermediate risk of malignancy, the patient was started with adjuvant imatinib 400 mg once daily due to probability of disease recurrence (24%).

在消化系统中,间充质来源的肿瘤非常罕见;通常,它们被认为是胃肠道间质瘤(GIST)。GIST的发生率非常低(十万分之二),而空肠GIST极为罕见,占所有胃肠道(GI)肿瘤的0.1-3%。小肠GIST是胃肠道中第二常见(25%)的部位,通常发生在十二指肠。我们报告了一例62岁的孟加拉国女性,3年前有胃肠道出血史;尽管进行了广泛的调查,但仍未找到出血的原因。与此同时,患者偶尔出现腹痛和右腹部肿块感,没有任何胃肠道出血。在计算机断层扫描中,鉴于小肠肠系膜肿块,进行了剖腹探查。在中线切口上,在离十二指肠空肠弯曲约30cm的空肠反肠交界处有一个6×6cm的肿块,切除后吻合。GIST的表现从无症状到轻度腹痛和肿块(5-50%)、机械性梗阻(5%)以及出血-穿孔不等,很少有报道(0.8%),这使得诊断变得困难。在18-30%的病例中发现了这些肿瘤的外生生长。鉴于恶性肿瘤的中等风险,由于疾病复发的可能性(24%),患者开始接受400 mg的伊马替尼辅助治疗,每日一次。
{"title":"Primary Jejunal Gastrointestinal Stromal Tumor: Diagnosis Delay of 3 Years but Successful Management in Early Stage (II) by Surgery and Adjuvant Therapy.","authors":"Ferdous Ara Begum,&nbsp;Md Arifur Rahman,&nbsp;Hashim Rabbi,&nbsp;Golam Mostofa,&nbsp;Qamruzzaman Chowdhury","doi":"10.1159/000496973","DOIUrl":"https://doi.org/10.1159/000496973","url":null,"abstract":"<p><p>In the digestive system, mesenchymal origin of tumors is quite rare; in general, they are recognized as gastrointestinal stromal tumors (GISTs). The incidence of GISTs is very low (2 in 100,000), while jejunal GISTs are extremely rare, accounting for 0.1-3% of all gastrointestinal (GI) tumors. Small intestinal GISTs are the second most common (25%) site in the GI tract, usually occurring in the duodenum. We present the case of a 62-year-old Bangladeshi female with a history of GI bleeding 3 years earlier; the cause of the bleeding had not been found despite extensive investigations. In the meantime, the patient had developed occasional abdominal pain and lumpy feelings in the right side of the abdomen without any GI bleeding. Exploratory laparotomy was carried out in view of a small intestinal mesenteric mass in a computed tomography scan. On midline incision there was a 6 × 6 cm mass in the antimesenteric border of the jejunum approximately 30 cm from the duodenojejunal flexure, which was resected followed by anastomosis. The presentation of GISTs ranges from asymptomatic to mild abdominal pain and mass (5-50%) and mechanical obstruction (5%) as well as hemorrhage - perforation having rarely been reported (0.8%) - making the diagnosis difficult. Exophytic growth of these tumors has been noted in 18-30% of cases. In view of intermediate risk of malignancy, the patient was started with adjuvant imatinib 400 mg once daily due to probability of disease recurrence (24%).</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1-2","pages":"36-42"},"PeriodicalIF":1.6,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000496973","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41215530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colorectal Cancer Prognosis: The Impact of Signet Ring Cell 结直肠癌预后:印戒细胞的影响
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-07-31 DOI: 10.1159/000501454
R. Bademci, J. Bollo, M. Carmen Martinez, Maria Pilar Hernadez, E. Targarona
Background: The prognosis for patients with colorectal cancer shows variation. The characteristics of colorectal cancer patients with signet-ring cell carcinoma (SRCC) are still not clear. Materials and Methods: A retrospective comparison was made of the data of signet-ring cell colorectal carcinoma patients operated on between 2009 and 2018 in respect of clinicopathological and operative results, morbidity, mortality, and long-term survival. Results: The study included a total of 34 patients comprising 26 (76%) males and 8 (24%) females with a mean age of 58 ± 11.7 years. Incidence of SRCC was determined as 1.8%. Lymphovascular invasion was determined in 22 (64%) patients. Tumors were determined as stage T2 in 8 (32%) patients, stage T3 in 9 (36%), and stage T4 in 8 (32%). According to the TNM classification, 5 (14.7%) patients were diagnosed with stage 1, 7 (20.6%) with stage 2, 15 (44.1%) with stage 3, and 7 (20.6%) with stage 4. The mean follow-up period was 40.6 ± 30.4 months, and mean disease-free follow-up was determined as 33.1 ± 36.1 months. Fifteen (44.1%) patients died because of the disease. Conclusion: Although SRCC is a poor prognostic factor, it should be kept in mind when determining adjuvant therapies and prognosis of patients determined with advanced-stage SRCC.
背景:癌症患者的预后存在差异。大肠癌癌症伴印戒细胞癌(SRCC)的特点尚不清楚。材料和方法:对2009年至2018年间接受手术的印戒细胞结直肠癌患者的临床病理和手术结果、发病率、死亡率和长期生存率进行回顾性比较。结果:该研究共纳入34名患者,包括26名(76%)男性和8名(24%)女性,平均年龄为58±11.7岁。SRCC的发生率确定为1.8%。淋巴血管侵犯确定为22例(64%)患者。肿瘤被确定为T2期的8例(32%),T3期的9例(36%),T4期的8名(32%)。根据TNM分型,5名(14.7%)患者被诊断为1期,7名(20.6%)患者诊断为2期,15名(44.1%)患者被确诊为3期,7人(206%)被诊断为4期。平均随访时间为40.6±30.4个月,平均无病随访时间为33.1±36.1个月。15名(44.1%)患者死于该病。结论:尽管SRCC是一个不良预后因素,但在确定晚期SRCC患者的辅助治疗和预后时,应牢记这一点。
{"title":"Colorectal Cancer Prognosis: The Impact of Signet Ring Cell","authors":"R. Bademci, J. Bollo, M. Carmen Martinez, Maria Pilar Hernadez, E. Targarona","doi":"10.1159/000501454","DOIUrl":"https://doi.org/10.1159/000501454","url":null,"abstract":"Background: The prognosis for patients with colorectal cancer shows variation. The characteristics of colorectal cancer patients with signet-ring cell carcinoma (SRCC) are still not clear. Materials and Methods: A retrospective comparison was made of the data of signet-ring cell colorectal carcinoma patients operated on between 2009 and 2018 in respect of clinicopathological and operative results, morbidity, mortality, and long-term survival. Results: The study included a total of 34 patients comprising 26 (76%) males and 8 (24%) females with a mean age of 58 ± 11.7 years. Incidence of SRCC was determined as 1.8%. Lymphovascular invasion was determined in 22 (64%) patients. Tumors were determined as stage T2 in 8 (32%) patients, stage T3 in 9 (36%), and stage T4 in 8 (32%). According to the TNM classification, 5 (14.7%) patients were diagnosed with stage 1, 7 (20.6%) with stage 2, 15 (44.1%) with stage 3, and 7 (20.6%) with stage 4. The mean follow-up period was 40.6 ± 30.4 months, and mean disease-free follow-up was determined as 33.1 ± 36.1 months. Fifteen (44.1%) patients died because of the disease. Conclusion: Although SRCC is a poor prognostic factor, it should be kept in mind when determining adjuvant therapies and prognosis of patients determined with advanced-stage SRCC.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"57 - 63"},"PeriodicalIF":1.6,"publicationDate":"2019-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000501454","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43447160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Lower Gastrointestinal Kaposi Sarcoma in HIV/AIDS: A Diagnostic Challenge HIV/AIDS患者下消化道卡波西肉瘤的诊断挑战
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-07-18 DOI: 10.1159/000500140
T. Olanipekun, S. Kagbo-Kue, Adekunbi Egwakhe, Maxi Mayette, Mesfin Fransua, M. Flood
Gastrointestinal Kaposi sarcoma (GI-KS) is the most common extra-cutaneous site of KS in HIV/AIDS, and the majority (75%) of affected patients are asymptomatic. GI-KS rarely occurs in the absence of cutaneous lesions. Opportunistic GI infections in HIV/AIDS and GI-KS can present with similar symptoms especially diarrhea, creating a diagnostic challenge. We present a 46-year-old homosexual male with a medical history of HIV/AIDS and neurosyphilis, who presented with 2 weeks of nonbloody diarrhea and abdominal discomfort. He was initially worked up for infectious diarrhea, initiated on highly active anti-retroviral (HAART) and supportively managed with rehydration therapy and analgesia. However, his clinical symptoms did not improve, necessitating abdomen/pelvic CT scan which revealed extensive recto-sigmoid colon thickening and pelvic lymphadenopathy. Due to a high suspicion of malignancy, diagnostic endoscopy and biopsy were done which showed colonic KS. He was treated with intravenous pegylated doxorubicin in addition to HAART which evidently resulted in significant clinical and radiological improvement. The diagnosis of GI-KS could be challenging in the presence of overlapping features with opportunistic GI infections and the absence of cutaneous manifestations of KS because clinicians tend to focus more on infectious etiology. We suggest that clinicians should consider GI-KS in the differential diagnosis of patients with HIV/AIDS that present with diarrhea and other nonspecific abdominal symptoms. Early endoscopic evaluation with biopsy could help to ensure the timely diagnosis and management of GI-KS and ultimately improve outcomes.
胃肠道卡波西肉瘤(GI-KS)是HIV/AIDS患者中最常见的皮肤外肉瘤,大多数(75%)患者无症状。GI-KS很少发生在没有皮肤病变的情况下。HIV/AIDS和GI- ks的机会性胃肠道感染可表现出类似的症状,尤其是腹泻,这给诊断带来了挑战。我们报告一名46岁男同性恋者,有HIV/AIDS和神经梅毒病史,表现为2周的非出血性腹泻和腹部不适。他最初被诊断为感染性腹泻,开始使用高效抗逆转录病毒(HAART)治疗,并辅以补液治疗和镇痛。然而,他的临床症状没有改善,需要腹部/盆腔CT扫描,显示广泛的直肠-乙状结肠增厚和盆腔淋巴结病。由于高度怀疑恶性肿瘤,诊断性内镜检查和活检显示结肠KS。他在HAART治疗的基础上静脉注射聚乙二醇化阿霉素,明显改善了临床和放射学。GI-KS的诊断可能具有挑战性,因为存在与机会性胃肠道感染重叠的特征,并且没有KS的皮肤表现,因为临床医生倾向于更多地关注感染病因。我们建议临床医生在诊断有腹泻和其他非特异性腹部症状的HIV/AIDS患者时应考虑GI-KS。早期内镜下活检评估有助于确保GI-KS的及时诊断和治疗,并最终改善预后。
{"title":"Lower Gastrointestinal Kaposi Sarcoma in HIV/AIDS: A Diagnostic Challenge","authors":"T. Olanipekun, S. Kagbo-Kue, Adekunbi Egwakhe, Maxi Mayette, Mesfin Fransua, M. Flood","doi":"10.1159/000500140","DOIUrl":"https://doi.org/10.1159/000500140","url":null,"abstract":"Gastrointestinal Kaposi sarcoma (GI-KS) is the most common extra-cutaneous site of KS in HIV/AIDS, and the majority (75%) of affected patients are asymptomatic. GI-KS rarely occurs in the absence of cutaneous lesions. Opportunistic GI infections in HIV/AIDS and GI-KS can present with similar symptoms especially diarrhea, creating a diagnostic challenge. We present a 46-year-old homosexual male with a medical history of HIV/AIDS and neurosyphilis, who presented with 2 weeks of nonbloody diarrhea and abdominal discomfort. He was initially worked up for infectious diarrhea, initiated on highly active anti-retroviral (HAART) and supportively managed with rehydration therapy and analgesia. However, his clinical symptoms did not improve, necessitating abdomen/pelvic CT scan which revealed extensive recto-sigmoid colon thickening and pelvic lymphadenopathy. Due to a high suspicion of malignancy, diagnostic endoscopy and biopsy were done which showed colonic KS. He was treated with intravenous pegylated doxorubicin in addition to HAART which evidently resulted in significant clinical and radiological improvement. The diagnosis of GI-KS could be challenging in the presence of overlapping features with opportunistic GI infections and the absence of cutaneous manifestations of KS because clinicians tend to focus more on infectious etiology. We suggest that clinicians should consider GI-KS in the differential diagnosis of patients with HIV/AIDS that present with diarrhea and other nonspecific abdominal symptoms. Early endoscopic evaluation with biopsy could help to ensure the timely diagnosis and management of GI-KS and ultimately improve outcomes.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"51 - 56"},"PeriodicalIF":1.6,"publicationDate":"2019-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000500140","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44157578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Frailty Predicts Severe Postoperative Complication after Elective Hepatic Resection 虚弱可预测选择性肝切除术后严重并发症
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-05-22 DOI: 10.1159/000500086
H. Okabe, H. Hayashi, T. Higashi, H. Nitta, Y. Ikuta, Toshihiko Yusa, H. Takeyama, K. Ogawa, N. Ozaki, S. Akahoshi, K. Ogata, Takayuki Osaki, H. Baba, H. Takamori
Background: Frail patients are likely to suffer from postoperative complication, but this assumption has not been well confirmed. Objectives: This study aims to clarify the importance of frailty in patients undergoing hepatectomy for predicting severe postoperative complications. Method: One hundred and forty-three patients aged >65 years undergoing hepatectomy between 2011 and 2016 were enrolled in this study. The relevance of frailty versus sarcopenia for postoperative outcome was assessed. We defined clinical frailty (CF) as a CF scale >4. Sarcopenia was defined by the total muscle area at the level of the third lumbar vertebra measured on computed tomography. Results: There were 16 patients (11%) with CF and 80 patients (56%) with sarcopenia. CF was associated with high age (p < 0.0001), severe postoperative complications (Clavien-Dindo classification ≥3) (p = 0.0059), and postoperative in-hospital stay (p = 0.0013). On the other hand, sarcopenia was not associated with postoperative outcome. Logistic regression analysis revealed that only CF was an independent predictor of severe postoperative complication (risk ratio of 4.2; p = 0.017). The occurrence of organ/space surgical site infection was significantly higher in the frailty group than in the non-frailty group. Conclusion: CF, but not sarcopenia, is a robust predictor of severe postoperative complications for patients undergoing hepatectomy.
背景:虚弱的患者可能会出现术后并发症,但这一假设尚未得到很好的证实。目的:本研究旨在阐明肝切除术患者虚弱对预测术后严重并发症的重要性。方法:在2011年至2016年间,143名年龄>65岁的患者接受了肝切除术。评估虚弱与少肌症对术后结果的相关性。我们将临床虚弱(CF)定义为CF量表>4。Sarcopenia是指在计算机断层扫描上测量的第三腰椎水平的总肌肉面积。结果:CF患者16例(11%),少肌症患者80例(56%)。CF与高年龄(p<0.0001)、严重的术后并发症(Clavien-Dindo分类≥3)(p=0.0059)和术后住院时间(p=0.0013)有关。另一方面,少肌症与术后结果无关。Logistic回归分析显示,只有CF是严重术后并发症的独立预测因素(风险比为4.2;p=0.017)。虚弱组器官/空间手术部位感染的发生率显著高于非虚弱组。结论:CF,而不是少肌症,是肝切除术后严重并发症的有力预测因素。
{"title":"Frailty Predicts Severe Postoperative Complication after Elective Hepatic Resection","authors":"H. Okabe, H. Hayashi, T. Higashi, H. Nitta, Y. Ikuta, Toshihiko Yusa, H. Takeyama, K. Ogawa, N. Ozaki, S. Akahoshi, K. Ogata, Takayuki Osaki, H. Baba, H. Takamori","doi":"10.1159/000500086","DOIUrl":"https://doi.org/10.1159/000500086","url":null,"abstract":"Background: Frail patients are likely to suffer from postoperative complication, but this assumption has not been well confirmed. Objectives: This study aims to clarify the importance of frailty in patients undergoing hepatectomy for predicting severe postoperative complications. Method: One hundred and forty-three patients aged >65 years undergoing hepatectomy between 2011 and 2016 were enrolled in this study. The relevance of frailty versus sarcopenia for postoperative outcome was assessed. We defined clinical frailty (CF) as a CF scale >4. Sarcopenia was defined by the total muscle area at the level of the third lumbar vertebra measured on computed tomography. Results: There were 16 patients (11%) with CF and 80 patients (56%) with sarcopenia. CF was associated with high age (p < 0.0001), severe postoperative complications (Clavien-Dindo classification ≥3) (p = 0.0059), and postoperative in-hospital stay (p = 0.0013). On the other hand, sarcopenia was not associated with postoperative outcome. Logistic regression analysis revealed that only CF was an independent predictor of severe postoperative complication (risk ratio of 4.2; p = 0.017). The occurrence of organ/space surgical site infection was significantly higher in the frailty group than in the non-frailty group. Conclusion: CF, but not sarcopenia, is a robust predictor of severe postoperative complications for patients undergoing hepatectomy.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"28 - 35"},"PeriodicalIF":1.6,"publicationDate":"2019-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000500086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42865746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma 新型融合转录物VTI1A-CFAP46在肝细胞癌中的检测
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-04-10 DOI: 10.1159/000496795
S. Tsuge, B. Saberi, Yulan Cheng, Zhixiong Wang, Amy K Kim, Harry T Luu, J. Abraham, M. Ybanez, J. Hamilton, F. Selaru, C. Villacorta-Martin, F. Schlesinger, B. Philosophe, A. Cameron, Qingfeng Zhu, R. Anders, A. Gurakar, S. Meltzer
Background: Hepatocellular carcinoma (HCC) is now the second-highest cause of cancer death worldwide. Recent studies have discovered a wide range of somatic mutations in HCC. These mutations involve various vital signaling pathways such as: Wnt/β-Catenin, p53, telomerase reverse transcriptase (TERT), chromatin remodeling, RAS/MAPK signaling, and oxidative stress. However, fusion transcripts have not been broadly explored in HCC. Methods: To identify novel fusion transcripts in HCC, in the first phase of our study, we performed targeted RNA sequencing (in HCC and paired non-HCC tissues) on 6 patients with a diagnosis of HCC undergoing liver transplantation. Results: As a result of these studies, we discovered the novel fusion transcript, VTI1A-CFAP46. In the second phase of our study, we measured the expression of wild-type VTI1A in 21 HCC specimens, which showed that 10 of 21 exhibited upregulation of wild-type VTI1A in their tumors. VTI1A (Vesicle Transport via Interaction with t-SNARE homolog 1A) is a member of the Soluble N-ethylmaleimide-Sensitive Factor (NSF) attachment protein receptor (SNARE) gene family, which is essential for membrane trafficking and function in endocytosis, autophagy, and Golgi transport. Notably, it is known that autophagy is involved in HCC. Conclusions: The link between novel fusion transcript VTI1A-CFAP46 and autophagy as a potential therapeutic target in HCC patients deserves further investigation. Moreover, this study shows that fusion transcripts are worthy of additional exploration in HCC.
背景:肝细胞癌(HCC)目前是全球第二大癌症死亡原因。最近的研究发现HCC中存在广泛的体细胞突变。这些突变涉及多种重要信号通路,如:Wnt/β-Catenin, p53,端粒酶逆转录酶(TERT),染色质重塑,RAS/MAPK信号传导和氧化应激。然而,融合转录物尚未在HCC中得到广泛的研究。方法:为了鉴定HCC中新的融合转录物,在我们研究的第一阶段,我们对6例诊断为HCC并接受肝移植的患者进行了靶向RNA测序(在HCC和配对的非HCC组织中)。结果:通过这些研究,我们发现了新的融合转录物VTI1A-CFAP46。在我们研究的第二阶段,我们测量了21例HCC标本中野生型VTI1A的表达,结果显示21例中有10例肿瘤中野生型VTI1A表达上调。VTI1A(通过与t-SNARE同源1A相互作用的囊泡运输)是可溶性n -乙基马酰亚胺敏感因子(NSF)附着蛋白受体(SNARE)基因家族的成员,在膜运输和内吞作用、自噬和高尔基转运中发挥重要作用。值得注意的是,我们知道自噬参与了HCC。结论:新型融合转录物VTI1A-CFAP46与自噬之间的联系作为HCC患者的潜在治疗靶点值得进一步研究。此外,本研究表明融合转录物在HCC中值得进一步探索。
{"title":"Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma","authors":"S. Tsuge, B. Saberi, Yulan Cheng, Zhixiong Wang, Amy K Kim, Harry T Luu, J. Abraham, M. Ybanez, J. Hamilton, F. Selaru, C. Villacorta-Martin, F. Schlesinger, B. Philosophe, A. Cameron, Qingfeng Zhu, R. Anders, A. Gurakar, S. Meltzer","doi":"10.1159/000496795","DOIUrl":"https://doi.org/10.1159/000496795","url":null,"abstract":"Background: Hepatocellular carcinoma (HCC) is now the second-highest cause of cancer death worldwide. Recent studies have discovered a wide range of somatic mutations in HCC. These mutations involve various vital signaling pathways such as: Wnt/β-Catenin, p53, telomerase reverse transcriptase (TERT), chromatin remodeling, RAS/MAPK signaling, and oxidative stress. However, fusion transcripts have not been broadly explored in HCC. Methods: To identify novel fusion transcripts in HCC, in the first phase of our study, we performed targeted RNA sequencing (in HCC and paired non-HCC tissues) on 6 patients with a diagnosis of HCC undergoing liver transplantation. Results: As a result of these studies, we discovered the novel fusion transcript, VTI1A-CFAP46. In the second phase of our study, we measured the expression of wild-type VTI1A in 21 HCC specimens, which showed that 10 of 21 exhibited upregulation of wild-type VTI1A in their tumors. VTI1A (Vesicle Transport via Interaction with t-SNARE homolog 1A) is a member of the Soluble N-ethylmaleimide-Sensitive Factor (NSF) attachment protein receptor (SNARE) gene family, which is essential for membrane trafficking and function in endocytosis, autophagy, and Golgi transport. Notably, it is known that autophagy is involved in HCC. Conclusions: The link between novel fusion transcript VTI1A-CFAP46 and autophagy as a potential therapeutic target in HCC patients deserves further investigation. Moreover, this study shows that fusion transcripts are worthy of additional exploration in HCC.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"11 - 27"},"PeriodicalIF":1.6,"publicationDate":"2019-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000496795","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43530101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Nested Stromal-Epithelial Tumor of the Liver: A Review 肝巢状基质上皮性肿瘤的研究进展
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-03-18 DOI: 10.1159/000496339
B. Geramizadeh
Background: Nested stromal-epithelial tumor (NSET) is a rare liver tumor, which is most commonly seen in the pediatric age group. To the best of our knowledge, there has been no published review on this rare tumor in the English literature so far. Summary: In this review, we will discuss all the reported details of the published cases, including demography, clinical presentation, molecular histogenesis, imaging, gross pathology and histopathology, immunohistochemical findings, treatment modalities, and outcome of NSET of the liver. Key Message: Thirty-eight cases of NSET have been reported in the last 20 years in the English literature. This tumor produces a very large and calcified mass in the liver and characteristically can present as Cushing syndrome. NSET is a nonbiliary and nonhepatocytic tumor with biphasic differentiation into 2 components of epithelial and stromal cells. The epithelial cells are arranged as nests of mildly atypical epithelial cells with a few mitotic figures. The stromal component is composed of myofibroblasts and desmoplastic stroma which often shows ossification and calcification. Immunohistochemically, this tumor is positive for both epithelial and mesenchymal markers. The majority of the reported cases in the literature had benign behavior with an indolent course.
背景:嵌套型间质上皮肿瘤(NSET)是一种罕见的肝脏肿瘤,最常见于儿童年龄组。据我们所知,到目前为止,英国文献中还没有关于这种罕见肿瘤的发表评论。摘要:在这篇综述中,我们将讨论已发表病例的所有报告细节,包括人口学、临床表现、分子组织发生学、影像学、大体病理学和组织病理学、免疫组织化学发现、治疗方式和肝脏NSET的结果。关键信息:在过去的20年中,英国文献中报道了38例NSET病例。这种肿瘤在肝脏中产生一个非常大的钙化块,其特征可表现为库欣综合征。NSET是一种非胆汁性和非肝细胞性肿瘤,具有向上皮细胞和基质细胞两种成分的双相分化。上皮细胞排列成轻度非典型上皮细胞的巢状,有少量有丝分裂象。基质成分由肌成纤维细胞和促结缔组织增生性基质组成,常表现为骨化和钙化。免疫组化显示,该肿瘤的上皮和间充质标志物均呈阳性。文献中报告的大多数病例都有良性行为,病程缓慢。
{"title":"Nested Stromal-Epithelial Tumor of the Liver: A Review","authors":"B. Geramizadeh","doi":"10.1159/000496339","DOIUrl":"https://doi.org/10.1159/000496339","url":null,"abstract":"Background: Nested stromal-epithelial tumor (NSET) is a rare liver tumor, which is most commonly seen in the pediatric age group. To the best of our knowledge, there has been no published review on this rare tumor in the English literature so far. Summary: In this review, we will discuss all the reported details of the published cases, including demography, clinical presentation, molecular histogenesis, imaging, gross pathology and histopathology, immunohistochemical findings, treatment modalities, and outcome of NSET of the liver. Key Message: Thirty-eight cases of NSET have been reported in the last 20 years in the English literature. This tumor produces a very large and calcified mass in the liver and characteristically can present as Cushing syndrome. NSET is a nonbiliary and nonhepatocytic tumor with biphasic differentiation into 2 components of epithelial and stromal cells. The epithelial cells are arranged as nests of mildly atypical epithelial cells with a few mitotic figures. The stromal component is composed of myofibroblasts and desmoplastic stroma which often shows ossification and calcification. Immunohistochemically, this tumor is positive for both epithelial and mesenchymal markers. The majority of the reported cases in the literature had benign behavior with an indolent course.","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"6 1","pages":"1 - 10"},"PeriodicalIF":1.6,"publicationDate":"2019-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000496339","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46566034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Gastrointestinal Tumors
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1